NONALCOHOLIC FATTY LIVER DISEASE

This adverse event was reported 196 times

These drugs are most commonly taken by patients reporting NONALCOHOLIC FATTY LIVER DISEASE:

# Drug Count
0 METHOTREXATE SODIUM 48
1 ETANERCEPT 47
2 METHOTREXATE 44
3 ADALIMUMAB 43
4 METFORMIN 43
5 LEFLUNOMIDE 42
6 TOFACITINIB 42
7 AZATHIOPRINE 40
8 METFORMIN ER 500 MG 38
9 METFORMIN ER 750 MG 38
See all common drugs associated with NONALCOHOLIC FATTY LIVER DISEASE

NONALCOHOLIC FATTY LIVER DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NICOTINAMIDE 19 0.0074
1 ESOMEPRAZOLE SODIUM 15 0.0062
2 TOLNAFTATE 7 0.0053
3 GOLD 21 0.0036
4 SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE 2 0.0026
5 ERGOCALCIFEROL 33 0.0011
6 NORGESTREL AND ETHINYL ESTRADIOL 1 0.0011
7 NADOLOL 8 0.0011
8 SARILUMAB 26 0.0009
9 HYALURONIC ACID 1 0.0009
See all drugs enriched for association with NONALCOHOLIC FATTY LIVER DISEASE